Mr Michael Thurn CEO Interview On Small Caps, page-58

I wonder if MPL is part of that "worlds first drug screening platform" as well?

Would certainly seem like a true candidate with a ton of fresh data..

Keep an eye on BOT Botanix , they are at the end of their FDA Application, climbed from 8.5 to 20c during the application process and tomorrow they will know if approval is given,, so I'm eagerly awaiting the Market reaction and corresponding SP movement..

I enjoyed MT's comment "Rapidly move forward to Orphan Drug Designation"
Plus his wrap up " PAA represents a significant investment opportunity" .. something that has been missing from the language of PAA..